Form 4: Medtronic President Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Harry Skip Kiil, EVP & President Cardiovascular of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.

Summary

  • Tax/exercise-price withholding: disposed of 3,074 Ordinary Shares at $85.39 ($262,489) on July 31, 2026; holds 34,439 after (Direct).
  • Grant/award: acquired 9,230 Ordinary Shares on August 3, 2026; holds 43,669 after (Direct).
  • Grant/award: acquired 23,074 Performance Share Units on August 3, 2026; holds 23,074 after (Direct).
  • Grant/award: acquired 65,556 Stock Option (Right to Buy) on August 3, 2026; holds 65,556 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Harry Skip Kiil — Officer (EVP & President Cardiovascular)

DateTransactionSecuritySharesPriceValueHeld After
2026-07-31Tax/exercise-price withholdingOrdinary Shares3,074$85$262.5K34,439
2026-08-03Grant/awardOrdinary Shares9,230——43,669
2026-08-03Grant/awardPerformance Share Units23,074——23,074
2026-08-03Grant/awardStock Option (Right to Buy)65,556——65,556

Key Dates

DateDescription
2026-07-31Tax/exercise-price withholding (3,074 shares)
2026-08-03Grant/award (9,230 shares)
2026-08-03Grant/award (23,074 shares)
2026-08-03Grant/award (65,556 shares)

Keywords

insider transaction, Form 4, MDT, Medtronic plc, neutral, Harry Skip Kiil

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.